These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27310943)
1. The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder. Chang TT; Chen SL; Chang YH; Chen PS; Chu CH; Chen SH; Huang SY; Tzeng NS; Wang LJ; Wang TY; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB; Lee SY Medicine (Baltimore); 2016 Jun; 95(24):e3488. PubMed ID: 27310943 [TBL] [Abstract][Full Text] [Related]
2. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder. Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924 [TBL] [Abstract][Full Text] [Related]
4. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis. Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116 [TBL] [Abstract][Full Text] [Related]
5. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436 [TBL] [Abstract][Full Text] [Related]
6. Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. Chang YH; Lee SY; Chen SL; Tzeng NS; Wang TY; Lee IH; Chen PS; Huang SY; Yang YK; Ko HC; Lu RB J Affect Disord; 2013 Dec; 151(3):967-72. PubMed ID: 24021960 [TBL] [Abstract][Full Text] [Related]
7. Association of the DRD2 CA Xu S; Liu J; Yang X; Qian Y; Xiao Q J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158 [TBL] [Abstract][Full Text] [Related]
9. DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis. Liu C; Xu X; Liu X; Zhang T; Li Y; Yan P Neurosci Lett; 2022 Aug; 786():136788. PubMed ID: 35835396 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor. Mao X; Wang T; Liu M; Chang X; Li N; Gu Y; Zhao D; Liao Q; Peng R J Clin Neurosci; 2013 Dec; 20(12):1644-9. PubMed ID: 24054403 [TBL] [Abstract][Full Text] [Related]
11. DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children. Firouzabadi N; Nazariat A; Zomorrodian K J Pharm Pharm Sci; 2017; 20(1):445-452. PubMed ID: 29249220 [TBL] [Abstract][Full Text] [Related]
12. No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Fathalli F; Rouleau GA; Xiong L; Tabbane K; Benkelfat C; Deguzman R; Zoltan D; Lal S; D'cruz S; Joober R Schizophr Res; 2008 Jan; 98(1-3):98-104. PubMed ID: 17698325 [TBL] [Abstract][Full Text] [Related]
14. Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors. Chen SF; Shen YC; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):470-4. PubMed ID: 19302829 [TBL] [Abstract][Full Text] [Related]
15. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations. Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931 [TBL] [Abstract][Full Text] [Related]
16. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis. Ma G; He Z; Fang W; Tang W; Huang K; Li Z; He G; Xu Y; Feng G; Zheng T; Zhou J; He L; Shi Y Schizophr Res; 2008 Apr; 101(1-3):26-35. PubMed ID: 18295456 [TBL] [Abstract][Full Text] [Related]
17. DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. Potvin S; Larouche A; Normand E; de Souza JB; Gaumond I; Grignon S; Marchand S J Pain; 2009 Sep; 10(9):969-75. PubMed ID: 19464960 [TBL] [Abstract][Full Text] [Related]
18. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Rybakowski JK; Borkowska A; Czerski PM; Hauser J Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801 [TBL] [Abstract][Full Text] [Related]
19. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054 [TBL] [Abstract][Full Text] [Related]
20. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]